Le rapport « Place des vaccins bivalents contre la Covid-19 Comirnaty Original/Omicron BA.1 et Comirnaty Original/Omicron BA.4-BA.5 », ci-joint, est adopté
Voir aussi
Recommandation vaccinale
20/09/2022
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
Ls7yRqZnLTFQu1Wd
